Research programme: common cold therapeutics - Select VaccinesAlternative Names: Picornavirus therapeutics research programme - Select Vaccines; SLT1; SLT2
Latest Information Update: 16 Jul 2016
At a glance
- Originator Select Vaccines
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Common cold
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Common cold in Australia
- 23 Aug 2004 Preclinical trials in Common cold in Australia (unspecified route)